Private equity faces heightened FCA and antitrust scrutiny

By Gregory Smith, Phil Kim and John Tilton, Sheppard Mullin Over the last five years, private equity (PE) firms have invested in excess of $450 billion in the healthcare industry – more than $250 billion of which can be accounted for in the past two years alone. This influx of capital also happens to coincide […]

The post Private equity faces heightened FCA and antitrust scrutiny appeared first on PE Hub.

Source: https://www.pehub.com/private-equity-faces-heightened-fca-and-antitrust-scrutiny/

Powered by WPeMatico